Nicole Davarpanah Negar's most recent trade in Cidara Therapeutics Inc was a trade of 62,597 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on Jan. 7, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Cidara Therapeutics Inc | Nicole Negar Davarpanah | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 07 Jan 2026 | 62,597 | 0 | - | - | Employee Stock Option (right to buy) | |
| Cidara Therapeutics Inc | Nicole Negar Davarpanah | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 07 Jan 2026 | 30,000 | 0 | - | - | Employee Stock Option (right to buy) | |
| Cidara Therapeutics Inc | Nicole Negar Davarpanah | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 07 Jan 2026 | 20,000 | 0 | - | - | Employee Stock Option (right to buy) | |
| Cidara Therapeutics Inc | Nicole Negar Davarpanah | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 221.50 per share. | 07 Jan 2026 | 12,553 | 8,333 (0%) | 0% | 221.5 | 2,780,490 | Common Stock |
| Cidara Therapeutics Inc | Nicole Negar Davarpanah | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 07 Jan 2026 | 11,000 | 0 | - | - | Employee Stock Option (right to buy) | |
| Cidara Therapeutics Inc | Nicole Negar Davarpanah | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 07 Jan 2026 | 8,333 | 0 (0%) | 0% | - | Common Stock | |
| Cidara Therapeutics Inc | Nicole Negar Davarpanah | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 07 Jan 2026 | 5,000 | 0 | - | - | Employee Stock Option (right to buy) | |
| Cidara Therapeutics Inc | Nicole Negar Davarpanah | Chief Medical Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 29 Dec 2025 | 450 | 20,886 (0%) | 0% | 0 | Common Stock | |
| Cidara Therapeutics Inc | Nicole Negar Davarpanah | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 219.60 per share. | 10 Dec 2025 | 10,332 | 21,286 (0%) | 0% | 219.6 | 2,268,907 | Common Stock |
| Cidara Therapeutics Inc | Nicole Davarpanah Negar | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 62.86 per share. | 11 Sep 2025 | 474 | 31,418 (0%) | 0% | 62.9 | 29,797 | Common Stock |
| Cidara Therapeutics Inc | Nicole Negar Davarpanah | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2025 | 20,000 | 20,000 | - | - | Employee Stock Option (right to buy) | |
| Cidara Therapeutics Inc | Nicole Negar Davarpanah | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2025 | 10,000 | 31,692 (0%) | 0% | 0 | Common Stock |